{"id":27343,"date":"2024-05-03T11:48:49","date_gmt":"2024-05-03T09:48:49","guid":{"rendered":"https:\/\/www.previsorageneral.com\/?p=27343"},"modified":"2024-05-07T16:03:46","modified_gmt":"2024-05-07T14:03:46","slug":"immunoterapia-cel%c2%b7lular-creix","status":"publish","type":"post","link":"https:\/\/www.previsorageneral.com\/ca\/immunoterapia-cel%c2%b7lular-creix\/","title":{"rendered":"Creix la immunoter\u00e0pia cel\u00b7lular"},"content":{"rendered":"<h2>Cient\u00edfics de la Facultat de Medicina de\u00a0Baylor\u00a0expandeixen aquest tipus de ter\u00e0pia a uns certs c\u00e0ncers en la sang, la qual cosa suposa una possibilitat de desenvolupar tractaments efica\u00e7os per a aquestes malalties.<\/h2> <p>&nbsp;<\/p> <p>La <strong>recerca cient\u00edfica obre les portes al desenvolupament de tractaments innovadors i efica\u00e7os<\/strong>. Aix\u00ed ho constaten certs treballs en aquest camp, com el que ha desenvolupat un grup d&#8217;investigadors del Centre del C\u00e0ncer Pedi\u00e0tric i del Centre de Ter\u00e0pia G\u00e8nica i Cel\u00b7lular de la Facultat de Medicina de Baylor, a Texas.<\/p> <p>Aquests investigadors han desenvolupat un nou assaig cl\u00ednic amb resultats molt favorables en la primera fase, els quals obren la porta a la possibilitat d&#8217;aplicar la immunoter\u00e0pia a tumors s\u00f2lids.<\/p> <h3>Immunoter\u00e0pia cel\u00b7lular: en qu\u00e8 consisteix?<\/h3> <p>El mecanisme d&#8217;aquest desenvolupament cient\u00edfic es basa a atacar una prote\u00efna anomenada HER2, la qual es troba en nivells molt alts en els casos de certs c\u00e0ncers en la sang. D&#8217;aquesta manera, <strong>s&#8217;obre la porta a la possibilitat de trobar un tractament efica\u00e7<\/strong> per a aquest conjunt de malalties.<\/p> <h3>Resultats positius<\/h3> <p>Encara que de moment es tracta d&#8217;un assaig en primera fase, els cient\u00edfics que hi van participar es mostren optimistes. Ara per ara, l&#8217;assaig anomenat HEROS 2.0 ha demostrat que l&#8217;<strong>enfocament terap\u00e8utic \u00e9s segur<\/strong> i que t\u00e9 beneficis cl\u00ednics.<\/p> <h3>La import\u00e0ncia de cuidar-se<\/h3> <p>A Previsora General som conscients de la import\u00e0ncia de cuidar-te a tu mateix i als teus. Per aquest motiu, <strong>t&#8217;oferim assegurances per a protegir la teva salut i la dels qui t&#8217;importen. Fes clic <a href=\"https:\/\/www.previsorageneral.com\/ca\/salut\/\">aqu\u00ed<\/a> per veure tota la nostra oferta<\/strong>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Cient\u00edfics de la Facultat de Medicina de\u00a0Baylor\u00a0expandeixen aquest tipus de ter\u00e0pia a uns certs c\u00e0ncers en la sang, la qual cosa suposa una possibilitat de desenvolupar tractaments efica\u00e7os per a aquestes malalties. &nbsp; La recerca cient\u00edfica obre les portes al&hellip;<\/p>\n","protected":false},"author":9,"featured_media":27344,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[39],"tags":[1258,5666,5566,5610],"post_series":[],"class_list":["post-27343","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-altres","tag-assegurances-de-salut","tag-immunoterapia","tag-recerca","tag-tractaments","entry","has-media"],"_links":{"self":[{"href":"https:\/\/www.previsorageneral.com\/ca\/wp-json\/wp\/v2\/posts\/27343","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.previsorageneral.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.previsorageneral.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.previsorageneral.com\/ca\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.previsorageneral.com\/ca\/wp-json\/wp\/v2\/comments?post=27343"}],"version-history":[{"count":2,"href":"https:\/\/www.previsorageneral.com\/ca\/wp-json\/wp\/v2\/posts\/27343\/revisions"}],"predecessor-version":[{"id":27347,"href":"https:\/\/www.previsorageneral.com\/ca\/wp-json\/wp\/v2\/posts\/27343\/revisions\/27347"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.previsorageneral.com\/ca\/wp-json\/wp\/v2\/media\/27344"}],"wp:attachment":[{"href":"https:\/\/www.previsorageneral.com\/ca\/wp-json\/wp\/v2\/media?parent=27343"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.previsorageneral.com\/ca\/wp-json\/wp\/v2\/categories?post=27343"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.previsorageneral.com\/ca\/wp-json\/wp\/v2\/tags?post=27343"},{"taxonomy":"post_series","embeddable":true,"href":"https:\/\/www.previsorageneral.com\/ca\/wp-json\/wp\/v2\/post_series?post=27343"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}